Slide background
Pharmacy Pharmacology Graduate Program

Pharmacy Pharmacology Graduate Program


Publications in International Scientific Journals(last two years)

2022
17. Tunctan, B.; Senol, S.; Temız-resıtoglu, M.; Yılmaz, D.; Guden, D.; Bahcelı, O.; Horat, M.; Sahan-fırat, S.; Sarı, A. Activation of GPR75 Signaling Pathway Contributes to the Effect of a 20-HETE Mimetic, 5,14-HEDGE, to Prevent Hypotensive and Tachycardic Responses to Lipopolysaccharide in a Rat Model of Septic Shock . JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79, 1-99.
https://journals.lww.com/cardiovascularpharm/Abstract/9900/Activation_of_GPR75_Signaling_Pathway_Contributes.11.aspx
16. Temiz reşitoğlu, M.; Güden, D.; şenol, .; Vezir, .; Sucu, N.; Kibar, D.; Yılmaz, .; Tunçtan, B.; Malik, K. Pharmacological Inhibition of Mammalian Target of Rapamycin Attenuates Deoxycorticosterone Acetate Salt-Induced Hypertension and Related Pathophysiology: Regulation of Oxidative Stress, Inflammation, and Cardiovascular Hypertrophy in Male Rats.. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79, 355-367.
2021
15. Guden, D.; Temiz-resitoglu, M.; Senol, S.; Kibar, D.; Yilmaz, S.; Tunctan, B.; Malik, K.; Sahan-firat, S. mTOR inhibition as a possible pharmacological target in the management of systemic inflammatory response and associated neuroinflammation by lipopolysaccharide challenge in rats. CANADIAN SCIENCE PUBLISHING, 2021, 0-0.
http://dx.doi.org/10.1139/cjpp-2020-0487
14. Naycı, S. . RESPIRATORY MEDICINE, 2021, , 1-9.
10.1016/j.rmed.2021.106433.
13. Tiftik, R.; Temiz reşitoğlu, M.; Güden, D.; Bayrak, G.; ün, .; Yılmaz, .; şahan fırat, S. . CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2021, 99, 418-426.
10.1139/cjpp-2020-0305
12. şenol, .; Temiz reşitoğlu, M.; Güden, D.; Sarı, A.; şahan fırat, S.; Tunçtan, B. . NEUROCHEMICAL RESEARCH, 2021, 46, 624-637.
10.1007/s11064-020-03197-7
11. Caglı, A.; şenol, .; Temiz reşitoğlu, M.; Güden, D.; Sarı, A.; şahan fırat, S.; Tunçtan, B. . DRUG DEVELOPMENT RESEARCH, 2021, 82, 815-825.
10.1002/ddr.21786
10. Güden, D.; Temiz reşitoğlu, M.; şenol, .; Kibar, D.; Yılmaz, .; Tunçtan, B.; Malik, K.; şahan fırat, S. . CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2021, 99, 921-934.
10.1139/cjpp-2020-0487
9. Naycı, S. . TURK J MED SCI, 2021, , -.
10.3906/sag-2001-239
2020
8. Senol, S.; Temiz-resitoglu, M.; Guden, D.; Sari, A.; Sahan-firat, S.; Tunctan, B. Suppression of TLR4/MyD88/TAK1/NF-κB/COX-2 Signaling Pathway in the Central Nervous System by Bexarotene, a Selective RXR Agonist, Prevents Hyperalgesia in the Lipopolysaccharide-Induced Pain Mouse Model. SPRINGER SCIENCE AND BUSINESS MEDIA LLC, 2020, 0-0.
http://dx.doi.org/10.1007/s11064-020-03197-7
7. Akbay, E. . LIPIDS IN HEALTH AND DISEASE, 2020, 19, 1-11.
10.1186/s12944-020-01408-2
6. Akbay, E. . DIABETES THERAPY, 2020, 11, 1045-1059.
10.1007/s13300-020-00779-0
5. Tunctan, B. CYP-derived eicosanoids in inflammatory diseases. ELSEVIER BV, 2020, 148, 106424-106424.
http://dx.doi.org/10.1016/j.prostaglandins.2020.106424
4. Tunçtan, B. . PROSTAGLANDINS OTHER LIPID MEDIATORS, 2020, 148, 106424-.
10.1016/j.prostaglandins.2020.106424
3. Biliktu, M.; şenol, .; Temiz reşitoğlu, M.; Güden, D.; Horat, M.; şahan fırat, S.; Sevim, M.; Tunçtan, B. . INFLAMMOPHARMACOLOGY, 2020, 28, 1509-1524.
10.1007/s10787-020-00691-w
2. Akbay, E. . LIPIDS IN HEALTH AND DISEASE, 2020, 19, -.
1. Biliktu, M.; şenol, .; Temiz reşitoğlu, M.; Güden, D.; Horat, F.; şahan fırat, S.; Sevim, S.; Tunçtan, B. . INFLAMMOPHARMACOLOGY, 2020, , -.